Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lack of imbalance between the master regulators TTF1/NKX2-1 and ΔNp63/p40 implies adverse prognosis in non-small cell lung cancer. | Sci Rep | 2024 | 38291083 | PubTator, text mining | PubMed |
| Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma. | Clin Transl Med | 2024 | 38279874 | PubTator, text mining | PubMed |
| Nuclear and mitochondrial genetic variants associated with mitochondrial DNA copy number. | Sci Rep | 2024 | 38267512 | PubTator, text mining | PubMed |
| The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives. | Life (Basel) | 2024 | 38255725 | PubTator, text mining | PubMed |
| Integrated analysis of FHIT gene alterations in cancer. | Cell Cycle | 2024 | 38234243 | PubTator, text mining | PubMed |
| Genome-wide exploration of genetic interactions for bladder cancer risk. | Int J Cancer | 2024 | 37638657 | PubTator, text mining | PubMed |
| HER2 Alterations in Non-Small Cell Lung Cancer: Biologico-Clinical Consequences and Interest in Therapeutic Strategies. | Life (Basel) | 2023 | 38255679 | PubTator, text mining | PubMed |
| Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study. | J Thorac Dis | 2023 | 38249933 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and Their Inhibitors as Potential Prognostic Biomarkers in Head and Neck Cancer after Radiotherapy. | Int J Mol Sci | 2023 | 38203696 | PubTator, text mining | PubMed |
| Copy Number Variations in Pancreatic Cancer: From Biological Significance to Clinical Utility. | Int J Mol Sci | 2023 | 38203561 | PubTator, text mining | PubMed |
| Trypanosoma cruzi, Chagas disease and cancer: putting together the pieces of a complex puzzle. | Front Cell Dev Biol | 2023 | 38188016 | PubTator, text mining | PubMed |
| Editorial: Community series in novel biomarkers for predicting response to cancer immunotherapy: volume II. | Front Immunol | 2023 | 38149255 | PubTator, text mining | PubMed |
| Pathogenetic Insights into Developmental Coordination Disorder Reveal Substantial Overlap with Movement Disorders. | Brain Sci | 2023 | 38137073 | PubTator, text mining | PubMed |
| Investigation of the IL7Rα Gene Polymorphism rs6897932 and the Expression Levels of the CDH1, TTPAL, and FHIT Genes in Patients with Breast Cancer. | P R Health Sci J | 2023 | 38104284 | PubTator, text mining | PubMed |
| Expression of Tumor Suppressor FHIT Is Regulated by the LINC00173-SNAIL Axis in Human Lung Adenocarcinoma. | Int J Mol Sci | 2023 | 38069335 | PubTator, text mining | PubMed |
| Chromosomal Instability in Gastric Cancer: Role in Tumor Development, Progression, and Therapy. | Int J Mol Sci | 2023 | 38069284 | PubTator, text mining | PubMed |
| Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies. | Int J Mol Sci | 2023 | 38069131 | PubTator, text mining | PubMed |
| [The development of selective XPO1 inhibitors in the treatment of acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38049328 | PubTator, text mining | PubMed |
| ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model. | Genome Biol | 2023 | 38037115 | PubTator, text mining | PubMed |
| Case report: Clinical management of recurrent small cell lung cancer transformation complicated with lung cancer-induced acute pancreatitis after lung adenocarcinoma surgery. | Front Pharmacol | 2023 | 38026982 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=4